The company will announce its preliminary results for the year ended 31 May 2024 on Wednesday 31 July 2024.

Investors can sign up to Investor Meet Company for free and add to meet Hargreaves Services plc here.

Management will host a Capital Markets Event for analysts, institutional investors, and media on Wednesday 17 July 2024 at 10.00 am – 12.30 pm (BST)

Analysts, institutional investors and media are welcome to attend the in-person event. Due to restrictions on numbers, it will not be possible for all interested parties to attend in-person, however, a live webcast will be available on the Company's website for retail investors and others to view the presentations here.

To register your interest for the event or webcast, please contact Walbrook PR on +44 20 7933 8780 or email [email protected]. A recording of the presentation will be made available on the Company's website after the event.

The company announce its audited results for the period ended 31 December 2023 on Friday 28 June 2024.

Investor presentation will be held via the Investor Meet Company platform on Wednesday, 10 July at 11am BST.

Investors can sign up to Investor Meet Company for free and add to meet ProBiotix Health plc here.

The company announce that Geoff Robertson, CEO will provide a live presentation relating to the Company’s Half Year Results via Investor Meet Company on 9 July 2024.

Management will hold the company’s AGM on 20 June 2024 at 2pm BST

The company will announce its final results for the year ended 31 December 2023 on Tuesday 4 June 2024.

The company will announce its audited final results for the year ended 31 December 2023 on Monday, 3 June 2024.

The company will announce its audited financial results for the year ended 31 December 2023 on Thursday, 30 May 2024.

The Company will host a Capital Markets Day on Wednesday 22 May 2024.

In person attendance at the Capital Markets Day is for institutional investors and analysts only. 

A live streamed webinar of the Capital Markets Day is available to all investors. Online attendees can register using the link here.  

Management will provide a presentation on Monday, 20 May 2024.

Investors can sign up to Investor Meet Company for free and add to meet OptiBiotix Health plc here.

Management will provide an update on the business and current trading on on Thursday, 16 May.

Investors can sign up to Investor Meet Company for free and add to meet Fusion Antibodies plc here.

Management will announce its audited full year results for the year ended 31 December 2023 on Wednesday 15 May 2024.

Management will report its third quarter fiscal year 2024 financial results on Wednesday, May 15, 2024 before U.S. market open.

A corresponding conference call and live webcast will be held at 8:30 a.m. (ET) / 1:30 p.m. (BST) on the day.

To register please click here. 

INFEX is hosting a live webinar to provide deeper insight into the Company, its strategy and lead pipeline assets on Thursday 9 May 2024 at 3pm BST.

The event will include presentations from the Infex senior management team along with a Q&A.

Please check here for more information and to register your interest: https://www.infextx.com/infex-to-present-webinar-on-broader-pipeline-and-growth-strategy/

Management expects to announce its audited results for the year ended 30 November 2023, on Wednesday 8 May 2024.

Management will announce its results for the 12 months ended 31 December 2023 on Thursday 25 April 2024.

Investor presentation to review the results and prospects will be held at 3pm on Tuesday 30 April 2024.

Management will announce its final results for the year ended 30 September 2023 on Tuesday 30 April 2024.

Management will announce its final results for 31 December 2023 on Tuesday 23 April 2024.

Management will host a Capital Markets Day on the morning of Tuesday 23 April 2024 from 09.00 to 13.00 BST.

Analysts and institutional investors are welcome to attend the event in the City of London and should contact [email protected] in order to register their interest.

For retail Investors, management will be hosting a remote investor Q&A session for retail investors at 16.30 BST on Tuesday 30 April.

Management will announce its audited results for the year ended 31 December 2023 on Thursday 18 April 2024.

Management will announce its final results for the year ended 30 September 2023 on Friday 12 April 2024.

Management will announce its full year results for the twelve months ended 31 December 2023 on Tuesday 9 April 2024.

Management will announce its interim results for the six months ended 31 December 2023 on 28 March 2024.

The Company will provide a live presentation on Friday, 5 April 2024.

Management will announce its Final results for the 12 months ended 31 December 2023 on Wednesday 20 March 2024.

Management will announce its an unaudited its final results for the year ended 31 December 2023 on 19 March 2024.

Management will announce its an unaudited its results for the 12 months ended 31 December 2023 on Monday 18 March 2024

Management will announce its interim results on Tuesday 27 February 2024.  for the six months ended on 31 December 2023.

Management will announce its unaudited trading update on Wednesday 21 February 2024 for the year ended on 31 December 2023.

Investor presentation will be held on Thursday 22 February 2024.

Management will announce its audited results on Wednesday 21 February 2024 for the six months to 30 November 2023

Management will announce its interim results and prospects on Monday 19 February 2024 for the six months ended on 31 December 2023.

Management will announce its an unaudited trading update for the year ended 31 December 2023 on 30 January 2024.

Management will hold a live presentation for Investors through the digital platform, Investor Meet Company, on Thursday 25 January 2024, relating to its H1 2023/24 Interim Results.

Management will hold a presentation for Investors through the digital platform, Investor Meet Company, on Wednesday 24 January 2024, relating to its the half-year reports for six months ended 30 November 2023.

Management will hold a presentation for Investors through the digital platform, Investor Meet Company, on Wednesday 24 January 2024, relating to its the half-year reports for six months ended 30 October 2023.

Management expected to hold a presentation for Investors through the digital platform, Investor Meet Company, on Tuesday 23 January 2024, relating to its the half-year reports for six months ended 31 October 2023.